PFCS
Pale Fire Capital SE Portfolio holdings
AUM
$958M
This Quarter Return
+21.88%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$995M
AUM Growth
+$995M
(-0.88%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-12.5%
Top 10 Holdings %
Top 10 Hldgs %
87.94%
Holding
78
New
28
Increased
5
Reduced
12
Closed
3
Top Buys
| 1 |
Alibaba
BABA
|
$6.07M |
| 2 |
Darling Ingredients
DAR
|
$2.54M |
| 3 |
Scorpio Tankers
STNG
|
$2.39M |
| 4 |
TripAdvisor
TRIP
|
$2.15M |
| 5 |
Virtu Financial
VIRT
|
$1.72M |
Top Sells
| 1 |
BP
BP
|
$108M |
| 2 |
Expedia Group
EXPE
|
$8.25M |
| 3 |
Talos Energy
TALO
|
$8.1M |
| 4 |
Arlo Technologies
ARLO
|
$4.34M |
| 5 |
OSG
Overseas Shipholding Group Inc.
OSG
|
$2.91M |
Sector Composition
| 1 | Energy | 70.44% |
| 2 | Communication Services | 13.35% |
| 3 | Consumer Staples | 9.22% |
| 4 | Industrials | 4.07% |
| 5 | Consumer Discretionary | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Prelude Therapeutics
PRLD
$68.5M
| $95.1K | 0.01% | +30,781 | New | +$95.1K |
|
|
CMRX
52
DELISTED
Chimerix, Inc.
CMRX
| $94.9K | 0.01% | +98,896 | New | +$94.9K |
|
53
Kura Oncology
KURA
$686M
| $91.7K | 0.01% | +10,050 | New | +$91.7K |
|
54
Edgewise Therapeutics
EWTX
$1.51B
| $89.6K | 0.01% | +15,645 | New | +$89.6K |
|
55
Aclaris Therapeutics
ACRS
$209M
| $89.1K | 0.01% | +13,000 | New | +$89.1K |
|
56
Compass Therapeutics
CMPX
$483M
| $89K | 0.01% | +45,155 | New | +$89K |
|
|
ATYR
57
aTyr Pharma
ATYR
$527M
| $88.3K | 0.01% | +55,857 | New | +$88.3K |
|
58
Erasca
ERAS
$445M
| $82.9K | 0.01% | +42,101 | New | +$82.9K |
|
59
Kezar Life Sciences
KZR
$28.9M
| $81.9K | 0.01% | +68,851 | New | +$81.9K |
|
60
Terns Pharmaceuticals
TERN
$609M
| $76.5K | 0.01% | +15,202 | New | +$76.5K |
|
61
Tenaya Therapeutics
TNYA
$184M
| $71.7K | 0.01% | +28,100 | New | +$71.7K |
|
62
Iovance Biotherapeutics
IOVA
$807M
| $68.7K | 0.01% | +15,100 | New | +$68.7K |
|
63
Passage Bio
PASG
$22.7M
| $64.9K | 0.01% | 98,662 | – | – |
|
|
NSTG
64
DELISTED
NanoString Technologies, Inc.
NSTG
| $62.3K | 0.01% | +36,200 | New | +$62.3K |
|
65
ReNew
RNW
$2.76B
| $54.3K | 0.01% | +10,000 | New | +$54.3K |
|
66
Cidara Therapeutics
CDTX
$1.66B
| $51.2K | 0.01% | +54,356 | New | +$51.2K |
|
67
Larimar Therapeutics
LRMR
$310M
| $47.6K | ﹤0.01% | +12,040 | New | +$47.6K |
|
68
TScan Therapeutics
TCRX
$102M
| $42.4K | ﹤0.01% | +16,575 | New | +$42.4K |
|
|
NGM
69
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $36.2K | ﹤0.01% | +33,800 | New | +$36.2K |
|
70
C4 Therapeutics
CCCC
$185M
| $35.7K | ﹤0.01% | 19,200 | – | – |
|
71
Mersana Therapeutics
MRSN
$36.5M
| $32.3K | ﹤0.01% | 25,400 | – | – |
|
72
BioAtla
BCAB
$26.7M
| $27K | ﹤0.01% | 15,883 | – | – |
|
|
GRTX
73
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $3.05K | ﹤0.01% | +17,400 | New | +$3.05K |
|
74
Alamos Gold
AGI
$12.8B
| – | – | -138,581 | Closed | -$1.65M |
|
75
Burford Capital
BUR
$3.06B
| – | – | -174,743 | Closed | -$2.13M |
|